Showing results (31-40 of 72) with videos related to
Sort By:
Pageof 8
Revue Medicale Suisse|August 25, 2022
[Focus on tirzepatide, a dual unimolecular GIP-GLP-1 receptor agonist in type 2 diabetes]André J Scheen, Régis P Radermecker, Nicolas PaquotRevue Medicale De Liege|March 15, 2024
[Don't neglect metabolic syndrome]André Scheen, Françoise Luyckx, Nathalie Esser, et al.Revue Medicale De Liege|October 10, 2025
[Semaglutide 2.4 mg (Wegovy®) for the management of clinical obesity with weight-related complications]André Scheen, Nathalie Esser, Jenny De Flines, et al.Revue Medicale Suisse|August 25, 2021
[Cardiovascular risk and type 1 diabetes]Alexandre Dondonne, Nicolas Paquot, Karine Fombellida, et al.Revue Medicale Suisse|September 26, 2008
[CB1 receptor inhibition and glucose metabolism: role of rimonabant in type 2 diabetes]André J Scheen, Nicolas Paquot, Luc F Van GaalNutrition (Burbank, Los Angeles County, Calif.)|May 18, 2010
Fructose and metabolic diseases: new findings, new questionsLuc Tappy, Kim A Lê, Christel Tran, et al.Biochemical Pharmacology|February 21, 2018
Lipid bilayer stress in obesity-linked inflammatory and metabolic disordersMarco A Gianfrancesco, Nicolas Paquot, Jacques Piette, et al.Obesity Research|March 12, 2002
Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patientsNicolas Paquot, André J Scheen, Mirjam Dirlewanger, et al.Diabetes Research and Clinical Practice|May 7, 2014
Inflammation as a link between obesity, metabolic syndrome and type 2 diabetesNathalie Esser, Sylvie Legrand-Poels, Jacques Piette, et al.Clinical Nutrition (Edinburgh, Scotland)|February 8, 2021
Effect of a high fructose diet on metabolic parameters in carriers for hereditary fructose intoleranceFrançois-Guillaume Debray, Kevin Seyssel, Marjorie Fadeur, et al.Pageof 8